Dr. Reddy’s launches Posaconazole Delayed-Release Tablets within the US Market

Dr. Reddy’s launches Posaconazole Delayed-Release Tablets within the US Market

by admin- Thursday, April 21st, 2022 04:16:13 PM

Dr. Reddy’s Laboratories announced the release of Posaconazole Delayed-Release Tablets, a hundred mg, the healing widely wide-spread equivalent to NOXAFIL (posaconazole) Delayed-Release Tablets, a hundred mg authorized with the aid of the US Food and Drug Administration (USFDA).

The NOXAFIL brand and familiar had U.S. Sales of about $one hundred forty.Eight million MAT for the maximum recent 365 days finishing in February 2022 in step with IQVIA.

Dr. Reddy’s Posaconazole Delayed-Release Tablets are available in a hundred mg strength in bottle count number sizes of 60.

News Updates